MedTrace Logo

Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients

NCT02616627 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-05-04

No results posted yet for this study

Summary

Aims:

1. To determine whether BMD and muscle mass were associated with fractures and other adverse events in dialysis patients.
2. To explore the effects of the interactions among FGF23, calcium, phosphate, PTH and vitamin D on low bone mineral density and sacropenia in dialysis patients.

Method:

In this study, the investigators plan to use DXA to screen for BMD, relevant novel bone microstructure parameters, and body composition in chronic dialysis patients. Also, the investigators plan to use blood testing to measure the blood level of FGF23, calcium, phosphate, PTH and vitamin D. The investigators conduct a prospectively follow up program for these participants to evaluate clinical courses and outcomes. Patients will receive DXA (including BMD and body composition) tests and blood work at baseline and one-year. Muscle power and physical performance will be measured at baseline, 6 months and one-year.

Conditions

  • Chronic Kidney Disease Requiring Chronic Dialysis
  • Osteoporosis

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Ding-Cheng Chan, MD, PhD · National Taiwan University Hospital, Chutung branch

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2021-03-31
Completion
2026-02-28

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02616627 on ClinicalTrials.gov